piperacillin has been researched along with l 743,872 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boral, OB; Cağatay, P; Keçeli, SA; Sonmez, N; Tamer, GS; Willke, A | 1 |
| Drover, DR; Elkomy, MH; Frymoyer, A; Hammer, GB; Purohit, PJ; Su, F; Sutherland, SM | 1 |
2 other study(ies) available for piperacillin and l 743,872
| Article | Year |
|---|---|
Interaction between caspofungin or voriconazole and cefoperazone-sulbactam or piperacillin-tazobactam by in vitro and in vivo methods.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Candida albicans; Candidiasis; Caspofungin; Cefoperazone; Drug Interactions; Echinocandins; Female; Lipopeptides; Mice; Mice, Inbred BALB C; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyrimidines; Sulbactam; Triazoles; Voriconazole | 2014 |
Antimicrobial Disposition During Pediatric Continuous Renal Replacement Therapy Using an Ex Vivo Model.
Topics: Amphotericin B; Anti-Infective Agents; Caspofungin; Continuous Renal Replacement Therapy; Dose-Response Relationship, Drug; Humans; Meropenem; Metabolic Clearance Rate; Models, Biological; Pediatrics; Piperacillin; Voriconazole | 2019 |